This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lamping, K. G. Search for Related Content PubMed PubMed Citation Articles by Lamping, K. G. Related Collections Cardiovascular Pharmacology Coronary circulation

(Circulation. 2002;105:1520.)
© 2002 American Heart Association, Inc.

Editorials

Enhanced Contractile Mechanisms in Vasospasm

Is Endothelial Dysfunction the Whole Story?

Kathryn G. Lamping, PhD

From the Departments of Internal Medicine and Pharmacology, University of Iowa and VA Medical Center, Iowa City, Iowa.

Correspondence to Kathryn Lamping, PhD, Medical Services (111), VA Medical Center, 601 Highway 6 West, Iowa City, IA 52246. E-mail kathryn-lamping@uiowa.edu

Key Words: Editorials • vasospasm • vasoconstriction • muscle, smooth • coronary disease

The importance of the endothelium in regulating vascular tone and reactivity is well recognized. The endothelium produces a variety of substances including nitric oxide (NO), prostaglandins, endothelin-1, and an unidentified hyperpolarization factor that control vascular tone, thrombus formation, platelet and leukocyte adhesion and aggregation, and cellular proliferation. Alterations in the synthesis or activity of these substances appear to play a major role in the pathogenesis of a variety of diseases. Emphasis has been placed on alterations in the generation and function of NO as an underlying mechanism for abnormal vascular reactivity in atherosclerosis and other vascular diseases. Studies in both animal models and humans demonstrate that NO-mediated responses are decreased in atherosclerosis, diabetes, and a wide variety of vascular diseases. But measurements of NO in atherosclerosis have produced variable results with decreases¹ and increases² in the levels of NO reported. Inactivation of NO by reactive oxygen species may account for the decrease in NO-mediated responses.³

See p 1545

Although the absence of vasodilator mechanisms may impair the ability of the coronary circulation to respond to increases in myocardial oxygen consumption or vasoactive substances, for vasospasm to occur, an increase in contractile mechanisms must also occur. Previous studies from the laboratory of Akira Takeshita and coworkers in animal models of coronary vasospasm have suggested that increased vascular contractions are primarily related to smooth muscle hyperreactivity.⁴ Takeshita and coworkers compared the relative contributions of abnormal endothelium-dependent responses versus smooth muscle function to enhanced vascular muscle contractions in a model of vasospasm to . . . [Full Text of this Article]

This article has been cited by other articles:

				T. Yada, H. Shimokawa, O. Hiramatsu, T. Kajita, F. Shigeto, E. Tanaka, Y. Shinozaki, H. Mori, T. Kiyooka, M. Katsura, et al. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo J. Am. Coll. Cardiol., February 15, 2005; 45(4): 599 - 607. [Abstract] [Full Text] [PDF]

				C. Barandier, X.-F. Ming, and Z. Yang Small G Proteins as Novel Therapeutic Targets in Cardiovascular Medicine Physiology, February 1, 2003; 18(1): 18 - 22. [Abstract] [Full Text] [PDF]